Recombinant PDCD1 (Cetrelimab Biosimilar) antibody

Catalog No. ABIN7488175

The Mammalian Cells Monoclonal anti-PDCD1 (Cetrelimab Biosimilar) antibody (ABIN7488175) specifically detects PDCD1 (Cetrelimab Biosimilar) in ELISA. The antibody is reactive with Human samples.

Quick Overview for Recombinant PDCD1 (Cetrelimab Biosimilar) antibody (ABIN7488175)

Target: PDCD1 (Cetrelimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This PDCD1 (Cetrelimab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-PDCD1 (Cetrelimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Cetrelimab Biosimilar - Anti-PDCD1, PD1, CD279 mAb

Characteristics: Antibody Type: IgG4-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for PDCD1 (Cetrelimab Biosimilar)

Target: PDCD1 (Cetrelimab Biosimilar)

Target Type: Biosimilar

Background: JNJ-63723283
Cetrelimab (JNJ-63723283) is a Programmed Cell Death Receptor-1 (PD-1) Inhibitor.

CAS-No: 2050478-92-5